Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis.
J Infect Dis
; 198(5): 664-72, 2008 Sep 01.
Article
en En
| MEDLINE
| ID: mdl-18662130
ABSTRACT
BACKGROUND:
We evaluated the effect of pretreatment with Toll-like receptor (TLR) agonists in a mouse model of herpes simplex virus type 1 (HSV-1) encephalitis.METHODS:
BALB/c mice received a single intraperitoneal or intranasal injection of polyinosinicpolycytidylic acid (poly IC), a TLR3 agonist; lipopolysaccharide (LPS), a TLR4 agonist; oligodeoxynucleotide (ODN), a TLR9 agonist; or control vehicle. Twenty-four hours later, animals were infected with 5000 plaque-forming units of HSV-1.RESULTS:
Mice that received intraperitoneal pretreatment with vehicle, LPS, and poly IC had survival rates of 7%, 13%, and 56%, respectively, and mean life expectancies of 156.80+/-9.56, 176.00+/-9.24, and 213.00+/-7.71 h, respectively (p< .05, poly IC group vs. other groups). Similarly, intranasal pretreatment with vehicle, LPS, ODN, and poly IC were associated with survival rates of 20%, 47%, 60%, and 94%, respectively, and mean life expectancies of 153.60+/-11.71, 188.80+/-12.97, 204.80+/-11.73, and 234.00+/-5.81 h, respectively (p< .05, ODN and poly IC groups vs. vehicle group). Pretreatment with intranasal poly IC induced early expression of several immune genes in the brain and resulted in a significantly lower virus load.CONCLUSION:
TLR3 stimulation by poly IC 24 h before infection reinforces a natural innate immune mechanism of neuroprotection against HSV-1.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Oligonucleótidos
/
Lipopolisacáridos
/
Poli I-C
/
Herpesvirus Humano 1
/
Encefalitis Viral
/
Receptores Toll-Like
Límite:
Animals
Idioma:
En
Revista:
J Infect Dis
Año:
2008
Tipo del documento:
Article
País de afiliación:
Canadá